A chief technology officer (CTO), also known as a chief technical officer or chief technologist, is an executive-level position in a company or other entity whose occupation is focused on the scientific and technological issues within an organization.
Brook Byers is a senior partner at Kleiner Perkins Caufield & Byers and the brother of Stanford University Professor Tom Byers and Atlanta, Georgia engineering entrepreneur Ken Byers.
Rosatom, also known as Rosatom State Nuclear Energy Corporation, the State Atomic Energy Corporation Rosatom or Rosatom State Corporation, is a Russian state corporation headquartered in Moscow that specializes in nuclear energy, nuclear non-energy goods and high-tech products. Established in 2007, the organization comprises more than 350 enterprises, including scientific research organizations, the nuclear weapons complex, and the world's only nuclear icebreaker fleet.
Ferring Pharmaceuticals is a Swiss multinational biopharmaceutical company specialising in areas such as reproductive health, maternal health, gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years.
VIB is a research institute located in Flanders, Belgium. It was founded by the Flemish government in 1995, and became a full-fledged institute on 1 January 1996. The main objective of VIB is to strengthen the excellence of Flemish life sciences research and to turn the results into new economic growth. VIB spends almost 80% of its budget on research activities, while almost 12% is spent on technology transfer activities and stimulating the creation of new businesses, in addition VIB spends approximately 2% on socio-economic activities. VIB is member of EU-LIFE, an alliance of leading life sciences research centres in Europe.
Fred Hassan, is a Pakistan-born American business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.
Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated (ACT), which was renamed to Ocata Therapeutics in November 2014. In February 2016 Ocata was acquired by Astellas for $379 million USD.
Defence Research & Development Establishment (DRDE) is an Indian defence laboratory of the Defence Research and Development Organisation (DRDO). Located in Gwalior, it is primarily involved in the research and development of detection and protection against toxic chemical and biological agents. DRDE is organised under the Life Sciences Directorate of DRDO. The present director of DRDE is Dr. Devendra Kumar Dubey.
Ann Van Gysel is a Belgian scientist and businesswoman. In 2011 she started Turnstone Communications, offering communications and business development services to biotech and pharma industry. She teaches science communications at the University of Antwerp and University of Ghent and is a director to the board of the Institute of Tropical Medicine Antwerp.
Dr. Cristina Garmendia y Mendizábal is a Spanish biologist and businesswoman. With no previous political career, she was appointed as Minister of Science and Innovation in April 2008 by the President of the Government of Spain, Jose Luis Rodriguez Zapatero.
The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute affiliated with three campuses of the University of California in the San Francisco Bay Area: Berkeley, San Francisco, and Santa Cruz. QB3's domain is the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science.
Corporate venture capital (CVC) is the investment of corporate funds directly in external startup companies. CVC is defined by the Business Dictionary as the "practice where a large firm takes an equity stake in a small but innovative or specialist firm, to which it may also provide management and marketing expertise; the objective is to gain a specific competitive advantage." Examples of CVCs include GV and Intel Capital.
The Cuban Neuroscience Center (CNEURO) is a research institute located in Playa, Havana City. It was founded in 1969 as one of the first groups in the world to use informatics for the analysis of the brain`s electrical activity. CNEURO was officially established in 1990 and is nowadays one of the BioCubaFarma institutions, that focuses on basic and applied research as well as the development of high technology in order to screen, diagnose and treat problems related to mental health. It has a DNV Healthcare accreditation.
Biopeople – Denmark's Life Science Cluster is a publicly funded partnership and National Center established, authorised, and funded by the Ministry for Science and Higher Education to improve innovation, collaboration and education within the National Danish Innovation System. Biopeople is established as a Center at the Faculty of Health and Medical Sciences at University of Copenhagen.
Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
Trevor Mervyn Jones, CBE PhD DSc (Hon) FRCP FMedSci FBPhS FRSM FRSC FLSW is a visiting professor at King's College London, and a former Head of R&D, at Wellcome. He continues to have a distinguished career in the pharmaceutical and biotech industry as well as in academia.
The European Innovation Council (EIC) was introduced by the European Commission to support the commercialization of high-risk, high-impact technologies in the European Union. The fully-fledged EIC was launched March 2021 under Horizon Europe and is part of the European Innovation Council and SMEs Executive Agency (EISMEA). Its goal is to aid researchers, start-ups and SMEs bring their innovations to market by providing funding, networking and partnership opportunities, and business acceleration services. In its latest form, the concept has been put forth by the EU Research Commissioner Carlos Moedas in mid-2015. The EIC has a budget of €10.1 billion to support innovations throughout the lifecycle from early stage research, to proof of concept, technology transfer, and the financing and scale up of start-ups and SMEs.
Jeffrey Leiden, M.D., Ph.D. is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020.
Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.
